Real-time enrollment status for this triple-negative breast cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:37 PM UTC
| NCT Number | NCT06841354 |
| Recruiting Status | Recruiting |
| Condition | Triple-Negative Breast Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,000 participants |
| Active Locations | 38 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 17, 2026: Clinical trial NCT06841354 is currently recruiting participants. This phase3 study for triple-negative breast cancer is actively seeking new participants at 38 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06841354 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 38 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06841354 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.